Over at MIT, Thomas Knight, Drew Endy, et al. continue to draw glowing press on the subject of synthetic biology. Here’s the Guardian talking about MIT’s new undergraduate synth bio curriculum.
The synthetic biology story has been a matter of breathless anticipation for the science journalists out there, and the anti-genetic modification zealots and religious conservatives have yet to start beating on it. As soon as we start hearing the first horrified Luddite outrage about MIT’s new program, I’ll know that it’s really arrived. Here’s Douglas Lauffenburger predicting the future.
In a field so loaded with possibilities, it is difficult for the
researchers to map out the future. Lauffenburger is certain that within 50 years, the entire pharmaceutical industry will operate on an engineered basis, eliminating the need for messy trial and error
methods of drug discovery.
I believe that. But 50 years is a mighty long time.